{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T04:15:43Z","timestamp":1725768943793},"publisher-location":"Basel","reference-count":76,"publisher":"Birkh\u00e4user Basel","isbn-type":[{"type":"print","value":"9783034872645"},{"type":"electronic","value":"9783034872621"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/978-3-0348-7262-1_38","type":"book-chapter","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T04:14:21Z","timestamp":1389240861000},"page":"273-281","source":"Crossref","is-referenced-by-count":0,"title":["Eicosanoids, Other Fatty Acid Metabolites and the Cardiovascular System: Are the Present Antithrombotic Approaches Rational?"],"prefix":"10.1007","author":[{"given":"M. R.","family":"Buchanan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Brister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Bertomeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"38_CR1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM198602203140806","volume":"314","author":"R Ross","year":"1986","unstructured":"Ross, R. (1986). The pathogenesis of atherosclerosis\u2013an update. N. Engl. J. Med. 314: 488\u2013500.","journal-title":"N. Engl. J. Med"},{"key":"38_CR2","first-page":"8","volume":"23","author":"MA Packham","year":"1986","unstructured":"Packham, M.A., Mustard, J.F. (1986). The role of platelets in the development and complications of atherosclerosis. Semin. Hematol. 23: 8\u201326.","journal-title":"Semin. Hematol"},{"key":"38_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/0005-2795(75)90144-0","volume":"379","author":"S Moore","year":"1975","unstructured":"Moore, S., Pepper, D.S., Cash, J.D. (1975). The isolation and characterisation of platelet factor 4 release from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity. Biochim. Biophys. Acta. 379: 370\u2013384.","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"38_CR4","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/ajplegacy.1975.228.6.1757","volume":"228","author":"JF Mustard","year":"1975","unstructured":"Mustard, J.F., Perry, D.W., Kinlough-Rathbone, R.L., Packham, M.A. (1975). Factors responsible for ADP-induced release reaction of human platelets. Am. J. Physiol. 228 (6): 1757\u20131768.","journal-title":"Am. J. Physiol"},{"key":"38_CR5","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1073\/pnas.71.10.3824","volume":"71","author":"M Hamberg","year":"1974","unstructured":"Hamberg, M., Svensson, J., Samuelsson, B. (1974). Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc. Natl. Acad. Sci. USA 71: 3824\u20133828.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"38_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.me.38.020187.000443","volume":"38","author":"R Ross","year":"1987","unstructured":"Ross, R. (1987). Platelet derived growth factor. Ann. Rev. Med. 38: 71\u201379.","journal-title":"Ann. Rev. Med"},{"key":"38_CR7","first-page":"48","volume-title":"The subendotheliun and thrombogenesis. Bull. N.Y","author":"MB Stemerman","year":"1972","unstructured":"Stemerman, M.B., Spaet, T.H. (1972). The subendotheliun and thrombogenesis. Bull. N.Y. Acad. Med. 48: 289\u2013301."},{"key":"38_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-4684-7787-0_7","volume":"104","author":"JF Mustard","year":"1978","unstructured":"Mustard, J.F., Packham, M.A., Kinlough-Rathbone, R. (1978). Platelets, thrombosis and atherosclerosis. Adv. Exp. Med. Biol. 104: 127\u2013144.","journal-title":"Adv. Exp. Med. Biol"},{"key":"38_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2141.1972.tb07080.x","volume":"23","author":"JP Keenan","year":"1972","unstructured":"Keenan, J.P., Solum, N.O. (1972). Quantitative studies on the release of platelet fibrinogen by thrombin. Br. J. Haematol. 23: 461\u2013466.","journal-title":"Br. J. Haematol"},{"key":"38_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/0304-4165(81)90056-8","volume":"678","author":"A Lajmanovich","year":"1981","unstructured":"Lajmanovich, A., Hudry-Clergeon, G., Freyssinet, J.M., Marguerie, G. (1981). Human factor VIII procoagulant activity and phospholipid interaction. Biochim. Biophys. Acta. 678: 132\u2013136.","journal-title":"Biochim. Biophys. Acta"},{"key":"38_CR11","unstructured":"Lipscomb, M.S., Walsh, P.N. Human platelet factor XI. (1979). Localization in platelet membranes of factor XI-like activity and its function distinction from plasma factor XI. J. Clin. Invest. 63: 1006 1014."},{"key":"38_CR12","doi-asserted-by":"crossref","unstructured":"Tuszynski, G.P., Bevacona, S.J., Schmaier, A.H., CoLman, R.W., Walsh, P.N. (1982). Factor XI antigen and activity in platelets. Blood 59:1148-","DOI":"10.1182\/blood.V59.6.1148.1148"},{"key":"38_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3181\/00379727-133-34533","volume":"133","author":"H Al-Mondhiry","year":"1970","unstructured":"Al-Mondhiry, H., Marcus, A.J., Spaet, T.H. (1970). On the mechanism of platelet function inhibition by acetylsalicylic acid. Proc. Soc. Exp. Dial. Med. 133: 632\u2013636.","journal-title":"Proc. Soc. Exp. Dial. Med"},{"key":"38_CR14","first-page":"868","volume":"89","author":"M Ali","year":"1977","unstructured":"Ali, M., McDonald, J.W.D. (1977). Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin. J. Lab. Clin. Med. 89: 868\u2013875.","journal-title":"J. Lab. Clin. Med"},{"key":"38_CR15","doi-asserted-by":"publisher","first-page":"12A","DOI":"10.1016\/0002-9149(91)90083-W","volume":"67","author":"JT Willerson","year":"1991","unstructured":"Willerson, J.T., Golino, P., McNatt, J. Eidt, J., Yao, S-K., Buja, L.M. (1991). Role of new antiplatelet agents as adjunctive therapies in thrombolysis. Am. J. Cardiol. 67: 12A - 18A.","journal-title":"Am. J. Cardiol"},{"key":"38_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/clpt.1989.12","volume":"45","author":"DC German","year":"1989","unstructured":"German, D.C., Kredich, N.M., Bjornsson, T.D. (1989). Oral dipyridamole increases plasma adenosine levels in human beings. Clin. Pharmacol. Ther. 45: 80\u201384.","journal-title":"Clin. Pharmacol. Ther"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1042\/bj1200020Pa","volume":"120","author":"JB Smith","year":"1970","unstructured":"Smith, J.B., Mills, D.C.B. (1970). Inhibition of adenosine 3\u2019:5\u2019-cyclic monophosphate phosphodiesterase. Biochem. J. 120: 20 P.","journal-title":"Biochem. J"},{"key":"38_CR18","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/S0140-6736(78)91269-2","volume":"1","author":"S Moncada","year":"1978","unstructured":"Moncada, S., Korburt, R. (1978). Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1: 1286\u20131289.","journal-title":"Lancet"},{"key":"38_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/01.CIR.80.4.749","volume":"80","author":"CH Hennekens","year":"1989","unstructured":"Hennekens, C.H., Buring, J.E., Sandercock, P., Collins, R., Peto, R. (1989). Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. . 80: 749\u2013756.","journal-title":"Circ"},{"key":"38_CR20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJM197211162872001","volume":"287","author":"LA Harker","year":"1972","unstructured":"Harker, L.A., Slichter, S.J. (1972). Platelet and fibrinogen consumption in man. N. Engl. J. Med. 287: 999\u20131005.","journal-title":"N. Engl. J. Med"},{"key":"38_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1056\/NEJM198001313020502","volume":"302","author":"The Anturane Reinfarction Trial Research Group","year":"1980","unstructured":"The Anturane Reinfarction Trial Research Group. (1980). Sulfinpyrazone in the prevention of sudden death after myocardial infarction. N. Engl. J. Med. 302: 250\u2013256.","journal-title":"N. Engl. J. Med"},{"key":"38_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1056\/NEJM197807132990201","volume":"299","author":"Canadian Cooperative Study Group","year":"1978","unstructured":"Canadian Cooperative Study Group. (1978). A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N. Engl. J. Med. 299: 53\u201359.","journal-title":"N. Engl. J. Med"},{"key":"38_CR23","unstructured":"Cairns, J., Turpie, A.G.G., ISIS-2. (1988). Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 350\u2013360."},{"key":"38_CR24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-2275(20)40694-7","volume":"19","author":"AJ Marcus","year":"1978","unstructured":"Marcus, A.J. (1978). The role of lipids in platelet function with particular reference to the arachidonic acid pathway. J. Lipid Res. 19: 793\u2013826.","journal-title":"J. Lipid Res"},{"key":"38_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0262-1746(86)90149-6","volume":"21","author":"MR Buchanan","year":"1986","unstructured":"Buchanan, M.R., Butt, R.N., Hirsh, J., Markham, B.A., Nazir, D.J. (1986). Role of Lipoxygenase metabolism in platelet function: effect of aspirin and salicylate. Prost. Leuk. Med. 21: 157\u2013168.","journal-title":"Prost. Leuk. Med"},{"key":"38_CR26","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0022-2275(20)38204-3","volume":"30","author":"MJ Broekman","year":"1989","unstructured":"Broekman, M.J., Eiroa, A.M., Marcus, A.J. (1989). Albumin redirects platelet eicosanoid metabolism toward 12(S)-hydroxyeicosatetraenoic acid. J. Lipid Res. 30: 1925\u20131932.","journal-title":"J. Lipid Res"},{"key":"38_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0161-4630(81)90081-1","volume":"6","author":"CE Dutilh","year":"1981","unstructured":"Dutilh, C.E., Haddeman, E., Don, J.A., Moor, F.T. (1981). The role of arachidonate lipoxygenase and fatty acids during irreversible blood platelet aggregation in vitro. Prost. Med. 6: 111\u2013126.","journal-title":"Prost. Med"},{"key":"38_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0262-1746(87)90032-1","volume":"26","author":"BES Gibson","year":"1987","unstructured":"Gibson, B.E.S., Buchanan, M.R., Barr, R.D., White J.G. (1987). Primary thrombocythaemia in childhood: Symptomatic episodes and their relationship to thromboxane A2, 6-keto-PGE1 and 12- hydroxyeicosatetraenoic acid production. A case report. Prost. Leuko. Med. 26: 221\u2013231.","journal-title":"Prost. Leuko. Med"},{"key":"38_CR29","first-page":"219","volume":"17","author":"I Morita","year":"1987","unstructured":"Morita, I., Murota S.I. (1987). Role of 12-lipoxygenase products of arachidonic acid on platelet aggregation. Adv. Prost. Throat. Leuko. Res. 17: 219\u2013223.","journal-title":"Adv. Prost. Throat. Leuko. Res"},{"issue":"3","key":"38_CR30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0090-6980(85)90103-0","volume":"29","author":"KS Herrman","year":"1985","unstructured":"Herrman, K.S. (1985). Lipoxygenase Products: Leukotrienes C4, D4, A4s breakdown products and 12-HPETE influence platelet aggregation in vivo. Prostaglandins 29, No 3: 459\u2013465.","journal-title":"Prostaglandins"},{"key":"38_CR31","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood.V54.6.1258.1258","volume":"13","author":"M Okuma","year":"1979","unstructured":"Okuma, M., Uchino, H. (1979). Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders. Blood 13: 1258\u20131271.","journal-title":"Blood"},{"key":"38_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0952-3278(89)90058-6","volume":"36","author":"J Ryn-McKenna Van","year":"1989","unstructured":"Van Ryn-McKenna, J., Buchanan, M.R. (1989). Relative effects of flurbiprofen on platelet 12- hydroxyeicosatetraenoic acid and thromboxane A2 production: Influence on collagen induced platelet aggregation and adhesion. Prost. Leuko. and Med. 36: 171\u2013174.","journal-title":"Prost. Leuko. and Med"},{"key":"38_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1172\/JCI110059","volume":"67","author":"MR Buchanan","year":"1981","unstructured":"Buchanan, M.R., Dejana, E., Gent, M. (1981). Enhanced platelet accumulation onto injured carotid arteries in rabbits after aspirin treatment. J. Clin. Invest. 67: 503\u2013508.","journal-title":"J. Clin. Invest"},{"key":"38_CR34","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/263663a0","volume":"263","author":"S Moncada","year":"1976","unstructured":"Moncada, S., Gryglewski, R., Bunting, S., Vane, J.R. (1976). An enzyme isolated form arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelets aggregation. Nature 263: 663\u2013665.","journal-title":"Nature"},{"key":"38_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0014-2999(88)90687-5","volume":"151","author":"MG Doni","year":"1988","unstructured":"Doni, M.G., Whittle, B.J.R., Palmer, R.M.J., Moncada, S. (1988). Actions of nitric oxide on the release of prostacycLin from bovine endothelial cells in culture. Eur. J. Pharm. 151: 19\u201325.","journal-title":"Eur. J. Pharm"},{"key":"38_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/01.ATV.10.6.1113","volume":"10","author":"JA Lopez","year":"1990","unstructured":"Lopez, J.A., Armstrong, M.L. Piegors, D.J., Heistad, D.D. (1990). Vascular responses to endothelin1 in atherosclerotic primates. Arteriosclerosis 10: 1113\u20131118.","journal-title":"Vascular responses to endothelin1 in atherosclerotic primates. Arteriosclerosis"},{"key":"38_CR37","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1172\/JCI111620","volume":"74","author":"EG Levin","year":"1984","unstructured":"Levin, E.G., Marzec, U., Anderson, J., Harker, L.A. (1984). Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J. Clin. Invest. 74: 1988\u20131995.","journal-title":"J. Clin. Invest"},{"issue":"21","key":"38_CR38","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1016\/S0021-9258(17)39071-3","volume":"260","author":"CM Hekman","year":"1985","unstructured":"Hekman, C.M., Loskutoff, D.J. (1985). Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J. Bio. Chem. 260, No 21: 11581\u201311587.","journal-title":"J. Bio. Chem"},{"key":"38_CR39","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1056\/NEJM199011223232101","volume":"323","author":"J Hsia","year":"1990","unstructured":"Hsia, J., Hamilton, W.P., Kleiman, N., Roberts, R., Ghaitman, B.R., Ross, A.M. (1990). A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. N. Engl. J. Med. 323: 1433\u20131437.","journal-title":"N. Engl. J. Med"},{"key":"38_CR40","unstructured":"Collen, D., Topol, E.J., Tiefenbrunn, A.J. et al. (1984). Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized-placebo controlled trial. Circ. 70: 1012\u20131017."},{"key":"38_CR41","doi-asserted-by":"publisher","first-page":"3A","DOI":"10.1016\/0002-9149(91)90082-V","volume":"67","author":"MH Prins","year":"1991","unstructured":"Prins, M.H., Hirsh J. (1991). Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarction. Am. J. Cardiol. 67: 3A - 11A.","journal-title":"Am. J. Cardiol"},{"key":"38_CR42","first-page":"132","volume":"20","author":"A Lotto","year":"1990","unstructured":"Lotto, A., Colombo, A., Talarico, G., Fratianne, G., Lettino, M. (1990). Heparin and secondary prevention of acute myocardial infarction. Haemostasis 20: 132\u2013141.","journal-title":"Haemostasis"},{"key":"38_CR43","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0022-2275(20)37913-X","volume":"24","author":"GM Denning","year":"1983","unstructured":"Denning, G.M., Figard, P.H., Kaduce, T.L., Spector, A. (1983). Role of triglycerides in endothelial cell arachidonic acid metabolism. J. Lipid Res. 24: 993\u20131011.","journal-title":"J. Lipid Res"},{"key":"38_CR44","doi-asserted-by":"crossref","unstructured":"Haas, T.A., Bertomeu, M.C., Bastida, E., Buchanan, M.R. Cyclic AMP regulation of endotheial cell triglyceride turnover, 13-hydroxyoctadecadienoic acid (13-HODE) synthesis and endothelial cell thrombogenecity. Biochim. Biophys. Acta. 1031: 174\u2013178.","DOI":"10.1016\/0167-4889(90)90190-O"},{"key":"38_CR45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0038-1661303","volume":"53","author":"MR Buchanan","year":"1985","unstructured":"Buchanan, M.R., Butt, R.W., Magas, Z., Van Ryn, J., Hirsh, J., Nazir, D.J. (1985). Endothelial cells produce a lipoxygenase derived chemorepellant with influences platelet\/endothelial cell interactions: effect of aspirin and salicylate. Thromb. Haemost. 53: 306\u2013311.","journal-title":"Thromb. Haemost"},{"key":"38_CR46","unstructured":"Buchanan, M.R., Haas, T.A, Lagarde, M., Guichardant, M. (1985). 13-hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J. Biol. Chem. 260: 16056\u201316059."},{"key":"38_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF00155590","volume":"8","author":"D Lauri","year":"1990","unstructured":"Lauri, D., Bertomeu, M.C., Orr, F.W., Bastida, E., Sauder, D., Buchanan, M.R. (1990). Interleukin-1 increases tumor cell adhesion to endothelial cells through an RGD dependant mechanism: in vitro and in vivo studies. Clin. Expl. Metastasis 8: 27\u201332.","journal-title":"Clin. Expl. Metastasis"},{"key":"38_CR48","first-page":"A1134","volume":"4","author":"RM Lafrenie","year":"1990","unstructured":"Lafrenie, R.M., Podor, T.J., Buchanan, M.R., Orr, F.W. (1990). Interleukin la induced vitronectin receptor expression and tumor cell endothelial cell adhesion. FASEB 4: A1134.","journal-title":"FASEB"},{"key":"38_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0092-8674(87)90233-9","volume":"48","author":"RO Hynes","year":"1987","unstructured":"Hynes, R.O. (1987). Integrins: a family of cell surface receptors. Cell 48: 549\u2013554.","journal-title":"Cell"},{"key":"38_CR50","first-page":"909","volume":"20","author":"MR Buchanan","year":"1991","unstructured":"Buchanan, M.R., Bertomeu, M.C., Haas, T.A., Gallo, S., Eltringham-Smith, L. (1991). Endothelial cell 13-HODE synthesis and tumor cell endothelial cell adhesion. Adv. Prost.Thromb.Leuko.Res. 20: 909\u2013912.","journal-title":"Adv. Prost.Thromb.Leuko.Res"},{"key":"38_CR51","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF00266409","volume":"93","author":"J Aznar-Salatti","year":"1990","unstructured":"Aznar-Salatti, J., Bastida, E., Buchanan, M.R., Castillo, R., Ordinas, A., Escolar, G. (1990). Differential localization of von Willebrand factor, fibronectin and 13-HODE in human endothelial cell cultures. Histochemistry 93: 507\u2013514.","journal-title":"Histochemistry"},{"key":"38_CR52","unstructured":"Conforti, G., Zanetti, A., Pasquali-Ronchetti, I., Ouaglino, D. Jr., Neyroz, P., Dejana, E. (1990). Modulation of vitronectin receptor binding by membrane lipid composition. J. BioL. Chem. 265: 4011\u20134019."},{"key":"38_CR53","first-page":"281","volume":"2","author":"E Bastida","year":"1990","unstructured":"Bastida, E., Bertomeu, M.C., Haas, T.A., Almirall, L., Lauri, D., Orr, F.W., Buchanan, M.R. (1990). Regulation of tumor cell adhesion by intracellular 13-HODE:15-HETE ratio. J. Lipid Med. 2: 281\u2013293.","journal-title":"J. Lipid Med"},{"key":"38_CR54","first-page":"1029","volume":"49","author":"IM Grossi","year":"1989","unstructured":"Grossi, I.M., Fitzgerald, L.A., Umbarger, L.A., Nelson, K.K., Diglio, C.A., Taylor, J.D., Honn, K.V. (1989). Bidirectional control of membrane expression and\/or activation of tumor cell IRGpIlb\/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. Canc. Res. 49: 1029\u20131037.","journal-title":"Canc. Res"},{"key":"38_CR55","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1055\/s-0038-1645958","volume":"58","author":"MR Buchanan","year":"1987","unstructured":"Buchanan, M.R., Richardson, M., Haas, T., Hirsh, J., Madri, J. (1987). The basement membrane underlying the vascular endothelium is not thrombogenic. Thromb. Haemost. 58: 698\u2013704.","journal-title":"Thromb. Haemost"},{"key":"38_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0306-9877(88)90014-X","volume":"27","author":"MR Buchanan","year":"1988","unstructured":"Buchanan, M.R., Bastida, E. (1988). Endothelium and underlying membrane reactivity with platelets, leukocytes and tumor cells: regulation by the lipoxygenase-derived fatty acid metabolites, 13-HODE and HETE.s. Med. Hypothesis, 27: 317\u2013325.","journal-title":"Med. Hypothesis"},{"key":"38_CR57","unstructured":"Aznar-Salatti, J., Bastida, E., Haas, T.A., Escolar, G., Ordinas, A., de Groot, P.H.G., Buchanan, M.R. (1991). The reactivity of the extracellular matrix with platelets is dependant upon the method of its preparation. Arterosclerosis, 11:In Press."},{"key":"38_CR58","first-page":"383","volume":"57","author":"E Weber","year":"1990","unstructured":"Weber, E., Haas, T.A., Mueller, T.H., Eisert, W.G., Hirsh, J. Richardson, M., Buchanan, M.R. (1990). Relationship between vessel wall 13-HODE synthesis and vessel wall thrombogenecity following injury. Influence of salicylate and dipyridamole treatment. Thromb. Res. 57: 383\u2013392.","journal-title":"Relationship between vessel wall 13-HODE synthesis and vessel wall thrombogenecity following injury. Influence of salicylate and dipyridamole treatment. Thromb. Res"},{"key":"38_CR59","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/0049-3848(90)90395-S","volume":"59","author":"Bertomeu,M.C.,Crozier,G.L.,Haas,T.A.,Fleith,M.,Buchanan, M.R","year":"1990","unstructured":"Bertomeu,M.C.,Crozier,G.L.,Haas,T.A.,Fleith,M.,Buchanan, M.R. (1990). Selective effects of dietary fats on vascular 13-MODE synthesis and platelet\/vessel wall interactions. Thromb. Res. 59: 819\u2013830.","journal-title":"Thromb. Res"},{"key":"38_CR60","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0049-3848(89)90433-7","volume":"55","author":"TC Simon","year":"1989","unstructured":"Simon, T.C., Makheja, A.N., Bailey, J.M. (1989). The induced lipoxygenase in atherosclerotic aorta converts linoleic acid to the platelet chemorepetlant factor 13-HODE. Thromb. Res. 55: 171\u2013178.","journal-title":"Thromb. Res"},{"key":"38_CR61","unstructured":"Brister, S.J., Haas, T.A., Bertomeu, M.C., Austin, J., Buchanan, M.R. (1990). 13-HODE synthesis in internal mammary arteries and saphenous veins: Implications in cardiovascular surgery. In: Adv. Prost. Thromb. Leuko. Res. 21:667\u2013670."},{"key":"38_CR62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1182\/blood.V77.1.5.5","volume":"77","author":"GJ Roth","year":"1991","unstructured":"Roth, G.J. (1991). Developing relationships: arterial platelet adhesion, glycoprotein lb, and leucine-rich glycoproteins. Blood 77: 5\u201319.","journal-title":"Blood"},{"key":"38_CR63","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1161\/01.CIR.80.6.1766","volume":"80","author":"BS Cotter","year":"1989","unstructured":"Cotter, B.S., Potts, J.D., Smith, S.R., Scudder, L.E., Jordan, R. (1989). Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb\/IIIa receptor:corretation with bleeding time, platelet aggregation, and blockade of GPIIb\/IIIa receptors. Circ. 80: 1766\u20131774.","journal-title":"Circ"},{"key":"38_CR64","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1161\/01.CIR.80.6.1918","volume":"80","author":"DJ Fitzgerald","year":"1989","unstructured":"FitzGerald, D.J. (1989). Platelet inhibition with an antibody to glycoprotein IIb\/IIIa. Circ. 80: 1918\u20131919.","journal-title":"Circ"},{"key":"38_CR65","first-page":"3774","volume":"76","author":"MI Siegel","year":"1979","unstructured":"Siegel, M.I., McConnell, R.T., Cuatrecasas, P. (1979). Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway. Biochemistry 76: 3774\u20133778.","journal-title":"Biochemistry"},{"key":"38_CR66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0140-6736(87)90001-8","volume":"1","author":"DA Wood","year":"1987","unstructured":"Wood, D.A., Riemeisma, R.A., Butler, S., Thomson, M., Macintyre, C., Elton, R.D., Oliver, M.F. (1987). Linoleic and eicosatetraenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet 1: 177\u2013183.","journal-title":"Lancet"},{"key":"38_CR67","first-page":"298","volume":"42","author":"MF Oliver","year":"1989","unstructured":"Oliver, M.F., Riemeisma, R.A., Thomson, M., Fulton, M., Abraham, R.A., Wood, D.A. (1989). Linoleic acid and coronary heart disease. Br. J. Hosp. Med. 42: 298\u2013300.","journal-title":"Br. J. Hosp. Med"},{"key":"38_CR68","unstructured":"Harker, L., Bernstein, E., Scala, T. (1990). Effect of aspirin\/dipyridamole on restenosis after carotid endarterectomy: randomized placebo controlled clinical trial. Circulation 80:III-5.(Abstr.)"},{"key":"38_CR69","first-page":"X","volume-title":"Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations","author":"Chesebro","year":"1990","unstructured":"Chesebro, J.N. (1990). Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations. Thromb. Res. X II: 5\u201310."},{"key":"38_CR70","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJM198809223191201","volume":"319","author":"GJ Dehmer","year":"1988","unstructured":"Dehmer, G.J., Popma, J.J., Van Den Berg, M.D., Eichhorn, E.J., Prewitt, J.B., Campbell, W.B., Jennings, L., Wilterson, J.T., Schmitz, J.M. (1988). Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N. Engl. J. Med. 319: 733\u2013740.","journal-title":"N. Engl. J. Med"},{"key":"38_CR71","first-page":"65","volume":"336","author":"GISSI-2","year":"1990","unstructured":"GISSI-2. (1990). A factorial randomised trial of aLteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 336: 65\u201371.","journal-title":"Lancet"},{"key":"38_CR72","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/01.CIR.81.1.219","volume":"81","author":"I-K Jang","year":"1990","unstructured":"Jang, I-K., Gold, H.K., Ziskind, A.A., Leinbach, R.C., Fallon, J.T., Cotten, D. (1990). Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. Circ. 81: 219\u2013225.","journal-title":"Circ"},{"key":"38_CR73","doi-asserted-by":"publisher","first-page":"19A","DOI":"10.1016\/0002-9149(91)90084-X","volume":"67","author":"PR Eisenberg","year":"1991","unstructured":"Eisenberg, P.R. (1991). Role of new anticoagulants as adjunctive therapy during thrombolysis. Am. J. Cardiol. 67: 19A - 24A.","journal-title":"Am. J. Cardiol"},{"key":"38_CR74","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/01.ATV.10.3.367","volume":"10","author":"UM Marzec","year":"1990","unstructured":"Marzec, U.M., Kelly, A.B., Hanson, S.R., Lasslo, A., Harker, L.A. (1990). Inhibition of thrombus formation in vivo by novel antiplatelet agent. Arteriosclerosis 10: 367\u2013371.","journal-title":"Arteriosclerosis"},{"issue":"2","key":"38_CR75","first-page":"77","volume":"1","author":"J Okwusidi","year":"1990","unstructured":"Okwusidi, J., Falcone, M., Van Ryn-McKenna, J., Hirsh, J., Ofosu, F.A., Buchanan, M.R. (1990). In vivo catalysis of thrombin inhibition by antithrombin III and heparin co-factor II and antithrombotic effect: Differential effects of dermatan sulfate and unfractioned heparin. Thromb. and Haemorrh. Dis. 1 \/2: 77\u201380.","journal-title":"Thromb. and Haemorrh. Dis"},{"key":"38_CR76","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/01.CIR.80.5.1347","volume":"80","author":"DD Dichek","year":"1989","unstructured":"Dichek, D.D., Neville, R.F., Zwiebel, J.A., Freeman, S.M., Leon, M.B., Anderson, W.F. (1989). Seeding of intravascutar stents with genetically engineered endothelial cells. Circ. 80: 1347\u20131353.","journal-title":"Circ"}],"container-title":["Prostaglandins in the Cardiovascular System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-0348-7262-1_38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:39:08Z","timestamp":1647905948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-0348-7262-1_38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"ISBN":["9783034872645","9783034872621"],"references-count":76,"URL":"https:\/\/doi.org\/10.1007\/978-3-0348-7262-1_38","relation":{},"subject":[],"published":{"date-parts":[[1992]]}}}